Absence of peliosis hepatis in patients receiving testosterone enanthate.
Fifty-two autopsies of patients who had undergone hemodialysis and had received testosterone enanthate, were reviewed for evidence of peliosis hepatis and liver neoplasms. Eight (15%) pathologic liver were isolated. No peliosis, adenoma or hepatoma was identified. These findings suggest that, unlike the 17-alpha derivatives of testosterone, testosterone enanthate is not associated with morphologic changes in the liver.
D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D006801:Humans; D008099:Liver / Q000473:pathology*; D008113:Liver Neoplasms / Q000139:chemically induced; D008875:Middle Aged; D010382:Peliosis Hepatis / Q000139:chemically induced* / Q000473:pathology; D013739:Testosterone / Q000009:adverse effects / Q000031:analogs & derivatives*
D013739:Testosterone; C004648:testosterone enanthate